Exit / M&A
Telix Pharmaceuticals strikes $3.3b merger with German radioisotope giant ITM
Melbourne's Telix Pharmaceuticals will merge with German radioisotope maker ITM in a deal worth as much as $3.3 billion, keeping about 76 per cent ownership with existing Telix shareholders once completed.
Also Biotech Dispatch